Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors
- PMID: 15702807
- DOI: 10.1016/S1081-1206(10)61277-X
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors
Comment on
-
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.Ann Allergy Asthma Immunol. 2004 Oct;93(4):360-4. doi: 10.1016/s1081-1206(10)61395-6. Ann Allergy Asthma Immunol. 2004. PMID: 15521372 Clinical Trial.
-
Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.Ann Allergy Asthma Immunol. 2005 Jan;94(1):29-33. doi: 10.1016/S1081-1206(10)61281-1. Ann Allergy Asthma Immunol. 2005. PMID: 15702812
-
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.Ann Allergy Asthma Immunol. 2005 Jan;94(1):34-8. doi: 10.1016/S1081-1206(10)61282-3. Ann Allergy Asthma Immunol. 2005. PMID: 15702813 Clinical Trial.
Similar articles
-
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization.J Asthma. 2004 Jun;41(4):375-84. doi: 10.1081/jas-120037650. J Asthma. 2004. PMID: 15281324 Review. No abstract available.
-
Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.Ann Allergy Asthma Immunol. 2008 Jan;100(1):82-5. doi: 10.1016/S1081-1206(10)60409-7. Ann Allergy Asthma Immunol. 2008. PMID: 18254487 Clinical Trial.
-
Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.Ann Allergy Asthma Immunol. 1999 Jun;82(6):554-8. doi: 10.1016/S1081-1206(10)63166-3. Ann Allergy Asthma Immunol. 1999. PMID: 10400483 Clinical Trial.
-
Sensitivity to nonsteroidal anti-inflammatory drugs.Ann Allergy Asthma Immunol. 2002 Dec;89(6):542-50; quiz 550, 605. doi: 10.1016/S1081-1206(10)62099-6. Ann Allergy Asthma Immunol. 2002. PMID: 12487218 Review.
-
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.Ann Allergy Asthma Immunol. 2005 Jan;94(1):34-8. doi: 10.1016/S1081-1206(10)61282-3. Ann Allergy Asthma Immunol. 2005. PMID: 15702813 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials